A carregar...

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

COL-3 is a chemically modified tetracycline that targets multiple aspects of matrix metalloproteinase regulation. This phase I clinical trial was conducted to determine the maximum tolerated dose (MTD) of COL-3 in adults with recurrent high-grade glioma, to describe the effects of enzyme-inducing an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rudek, Michelle A., New, Pamela, Mikkelsen, Tom, Phuphanich, Surasak, Alavi, Jane B., Nabors, Louis B., Piantadosi, Steven, Fisher, Joy D., Grossman, Stuart A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3197967/
https://ncbi.nlm.nih.gov/pubmed/21547395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-011-0602-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!